CSL112 infusion did not reduce major cardiovascular events at 90 days but further analysis suggests patients with elevated LDL-C levels could derive significant benefit.
Erlanger Gastroenterology Team Instrumental To International Study Success, Publication chattanoogan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chattanoogan.com Daily Mail and Mail on Sunday newspapers.
Federal housing programs appear to protect residents from lead exposure medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.